Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Selexis S.A.. (9/15/17). "Press Release: Selvita Demonstrates Strong Revenue Growth in H1 2017". Kraków.

Organisations Organisation Selvita S.A. (WSE:SLV)
  Group Selvita (Group)
  Organisation 2 Berlin-Chemie AG
  Group Menarini (Group)
Products Product drug discovery services
  Product 2 SEL24 (dual PIM/FLT3 kinase inhibitor, Selvita / Menarini)
Index term Index term Menarini–Selvita: kinase inhibitor, 201703– license ww to dual PIM/FLT3 kinase inhibitor SEL24 to Berlin-Chemie
     


Selvita, one of the largest drug discovery companies in Europe, has published semiannual financial results.

In H1 2017 Selvita Group recognized total operating revenues (incl. grants) of PLN 59.7 MM, which means a 109% increase compared to H1 2016 when the operating revenues amounted to PLN 28.5 MM.

Sales revenues increased in all of Selvita operating segments:

– Revenues from the services segment showed a solid increase of 31% (PLN 19.6 MM vs. PLN 14.9 MM).

– Revenues of the innovation (pipeline) segment rose very significantly by 337% (PLN 28.3 vs. PLN 6.4 MM). High dynamics of sales and operating profit in the innovation segment of the Group in H1 2017 was driven mainly by the partnering deal on SEL24 program with Berlin Chemie/Menarini.

– The bioinformatics segment has generated a 190% increase in revenues (PLN 3.1 MM vs. PLN 1.2 MM).

In H1 2017 revenues from subsidies increased by 38% in comparison to the H1 2016 (PLN 7.8 MM vs. PLN 5.6 MM).

The results show clearly that the company is growing strong across all divisions, enjoying stable and balanced business growth.

Group’s net profit amounted to PLN 8.8 MM versus PLN 0.3 MM in H1 2016.


The English version (Summary) of Selvita Consolidated Quarterly Report for H1 2017 is available at: [ https://selvita.com/wp-content/uploads/2017/09/Report-ESPI-PSr-2017.pdf ]

   
Record changed: 2017-09-25

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Selvita (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px download




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px